Fay Chinnery

ORCID: 0000-0002-8082-9016
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Health and Medical Research Impacts
  • Health Systems, Economic Evaluations, Quality of Life
  • Acne and Rosacea Treatments and Effects
  • Meta-analysis and systematic reviews
  • Healthcare cost, quality, practices
  • T-cell and B-cell Immunology
  • Chronic Lymphocytic Leukemia Research
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Marine and coastal ecosystems
  • Aquatic Ecosystems and Phytoplankton Dynamics
  • Pharmaceutical industry and healthcare
  • Health Sciences Research and Education
  • Tissue Engineering and Regenerative Medicine
  • CNS Lymphoma Diagnosis and Treatment
  • Pharmacological Effects of Natural Compounds
  • HER2/EGFR in Cancer Research
  • Ethics in Clinical Research
  • 3D Printing in Biomedical Research
  • Dermatology and Skin Diseases
  • Global Public Health Policies and Epidemiology
  • Skin Protection and Aging
  • Lymphoma Diagnosis and Treatment
  • Marine Biology and Ecology Research
  • Vitamin C and Antioxidants Research

University of Southampton
2003-2021

Southampton General Hospital
2021

University Hospital Southampton NHS Foundation Trust
2020

NIHR Evaluation Trials and Studies Coordinating Centre
2013-2018

Wessex Institute of Technology
2018

National Institute for Health Research
2013-2018

Faculty (United Kingdom)
2012

Energy metabolism is intrinsic to cell viability but surprisingly has been little studied in human embryonic stem cells (hESCs). The current study aims investigate the effect of environmental O2 tension on carbohydrate utilisation hESCs. Highly pluripotent hESCs cultured at 5% consumed significantly more glucose, less pyruvate and produced lactate compared those maintained 20% O2. Moreover, atmospheric levels expressed OCT4, SOX2 NANOG than To determine whether this difference was a...

10.1371/journal.pone.0062507 article EN cc-by PLoS ONE 2013-05-06

Cross-presentation is the presentation by MHC class I of antigenic peptides from exogenous proteins that have been internalized and processed professional antigen-presenting cells, e.g. dendritic cells. We investigated influence particle size antigen load on cross-presentation following delivery microspheres (MS). small particles (0·8-μm) sensitive to proteasome inhibition blockade endoplasmic reticulum-resident complex export, whereas larger (aggregated clumps 0·8-μm MS) resistant these...

10.1111/j.1365-2567.2012.03558.x article EN Immunology 2012-01-20

HTA Programme funding is governed by the need for evidence and scientific quality, reflecting of National Institute Health Research (NIHR) NHS. The criterion incorporates covering spectrum diseases, but also taking account research supported other funders. This study compared NIHR portfolio with UK burden disease as measured Disability-adjusted Life Years (DALYs). A retrospective cross-sectional using a cohort all funded primary syntheses projects received from April 2011 to March 2016 (n =...

10.1186/s13063-018-2489-7 article EN cc-by Trials 2018-02-02

Introduction Acne is one of the most common inflammatory skin diseases worldwide and can have significant psychosocial impact cause permanent scarring. Spironolactone, a potassium-sparing diuretic, has antiandrogenic properties, potentially reducing sebum production hyperkeratinisation in acne-prone follicles. Dermatologists prescribed spironolactone for acne women over 30 years, but robust clinical study data are lacking. This seeks to evaluate whether clinically effective cost-effective...

10.1136/bmjopen-2021-053876 article EN cc-by BMJ Open 2021-08-01

To assess the time to publication of primary research and evidence syntheses funded by National Institute for Health Research (NIHR) Technology Assessment (HTA) Programme published as a monograph in journal article wider biomedical literature.Retrospective cohort study.Primary synthesis projects HTA were included if they registered NIHR programmes database was planned submit draft final report on or before 9 December 2011.The median at 30 months an external determined searching website.Of...

10.1136/bmjopen-2013-004121 article EN cc-by-nc BMJ Open 2013-11-01

Natural killer (NK) cells play a critical role in antitumor immunity, their activation being regulated through NK cell receptors. Although the endogenous ligands for these receptors are largely unknown, viral have been identified. We investigated ability of an activating receptor ligand derived from mumps virus, haemagglutinin-neuraminidase (HN) to enhance against tumor cells. HN-expressing B16.OVA induced stronger compared with and also promoted dendritic (DC) toward DC1 phenotype, vitro....

10.4161/onci.20636 article EN OncoImmunology 2012-05-31

Innovations resulting from research have both national and global impact, so selecting the most promising studies to fund is crucial. Peer review of funding applications part selection process, requires considerable resources. This study aimed elicit stakeholder opinions about which factors contribute influence effective peer UK National Institute for Health Research (NIHR), identify possible minor improvements current processes any major changes or potential innovations achieve a more...

10.1136/bmjopen-2018-022548 article EN cc-by-nc BMJ Open 2018-12-01

<ns4:p><ns4:bold>Background:</ns4:bold> Over 13,000 new cases of non-Hodgkin’s lymphoma (NHL) are diagnosed in the UK, with approximately 4,900 attributable deaths each year. Diffuse Large B-cell Lymphoma (DLBCL) is most common NHL comprising one third adult cases. R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone) accepted as international standard first-line regimen, but improvement first line treatment needed. Dysregulated receptor (BCR) signalling has been...

10.12688/f1000research.22318.1 preprint EN cc-by F1000Research 2020-08-07

<ns7:p><ns7:bold>Background: </ns7:bold>Anthracycline- and taxane-based regimens form the mainstay of chemotherapy treatment in metastatic breast cancer. In patients who develop resistance to these agents, management options are limited there is no standard care. Thus, investigation into other chemotherapeutic agents warranted.</ns7:p><ns7:p> <ns7:bold>Methods: </ns7:bold>In this non-randomised prospective trial, with human epidermal growth factor 2 (HER-2)-negative locally advanced or...

10.12688/f1000research.21804.1 preprint EN cc-by F1000Research 2020-01-06

Objective Previous work has shown that 98% of NIHR Health Technology Assessment (HTA) Programme projects publish in (the peer reviewed journal for the HTA Programme). 68% clinical trials funded by US NIH publish, with 46% publishing within 30 months trial completion. This study aimed to assess time-to-publication primary research (trials, diagnostic studies, surveys and modelling projects) compare this other funding bodies.

10.1186/1745-6215-14-s1-p69 article EN cc-by Trials 2013-11-01

INTRODUCTION: It takes on average 17 years to translate a promising laboratory development into better patient treatments or services. About 10 of this innovation process lies within the National Institute for Health Research (NIHR) research pathway. Innovations developed through have both national and global impact, so selecting most studies fund is crucial. Peer review applications part NIHR funding process, but requires considerable resources. The committed improving efficiency...

10.1017/s0266462317002434 article EN International Journal of Technology Assessment in Health Care 2017-01-01

INTRODUCTION: This study compared the National Institute for Health Research (NIHR) Technology Assessment (HTA) Programme portfolio of research with united Kingdom (UK) burden disease, as measured by Disability-Adjusted Life Years (DALYs). METHODS: Design: Cross-sectional study. Setting: The HTA cohort included all funded applications (n = 363) received during period 1 April 2011 to 31 March 2016. sample contained primary and evidence syntheses, purely methodological studies were excluded...

10.1017/s0266462317001180 article EN International Journal of Technology Assessment in Health Care 2017-01-01

Introduction: The National Institute for Health Research (NIHR) is a major funder of health research in the United Kingdom. Selecting most promising studies to fund crucial, and external expert peer review used inform funding boards. Our aim was evaluate influence different kinds numbers reviewer scores on Board decisions, how we might modify process reduce workload stakeholders. Methods: mixed method study included i) retrospective cross sectional analysis board second stage applications...

10.1017/s0266462318001460 article EN International Journal of Technology Assessment in Health Care 2018-01-01
Coming Soon ...